| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 225.5K | $10.94M | -2,034 | |
| VP | 109.2K | $5.30M | - | |
| VP | 69.4K | $3.37M | -9,000 | |
| Dir | 43.3K | $2.10M | -44,472 | |
| CFO | 36.7K | $1.78M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2019 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 50,000 | $33.63 | $1,681,740.00 | -6.5% | |
| Mar 1, 2019 | Mitchell Paul J | Director | Sale+OE | 1,000 | $33.48 | $33,480.00 | -100% | |
| Feb 1, 2019 | Mitchell Paul J | Director | Sale+OE | 1,000 | $32.73 | $32,730.00 | -100% | |
| Jan 4, 2019 | Mitchell Paul J | Director | Sale+OE | 1,000 | $30.00 | $30,000.00 | -100% | |
| Dec 12, 2018 | Anstice David W | Director | Sale+OE | 8,787 | $35.59 | $312,710.24 | -4.2% | |
| Dec 3, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $36.45 | $36,450.00 | -100% | |
| Nov 2, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $37.51 | $37,510.00 | -100% | |
| Oct 1, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $42.42 | $42,420.00 | -100% | |
| Sep 4, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $44.58 | $44,580.00 | -100% | |
| Aug 1, 2018 | Mitchell Paul J | Director | Sale+OE | 1,000 | $43.68 | $43,680.00 | -100% |